Last $5.45 USD
Change Today +0.04 / 0.74%
Volume 202.8K
NEO On Other Exchanges
As of 8:10 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George A. Cardoza

Chief Financial Officer, Neogenomics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2013


Mr. George A. Cardoza has been the Chief Financial Officer of Neogenomics Inc., since November 2009. Mr. Cardoza served as the Chief Financial Officer of Neogenomics Laboratories, Inc. He served as an Executive Vice President and Chief Financial Officer of Protocol Services Acquisition Corp. Mr. Cardoza joined NeoGenomics in November 2009. He has over 25 years of financial experience. He most recently served as Chief Financial Officer and Executive Vice President of ...

Read Full Background

Corporate Headquarters*

12701 Common Wealth Drive
Fort Myers, Florida 33913

United States

Phone: 239-768-0600
Fax: 239-690-4237

Board Members Memberships*

There is no Board Members Memberships data available.


Syracuse University
Michigan State University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$305,500

Stock Options*

Exercisable Options205,000
Unexercisable Options25,000
Total Number of Options230,000

Total Compensation*

Total Annual Cash Compensation$310,090
Total Short Term Compensation$305,500
Total Calculated Compensation$325,806
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $5.45 USD +0.04


Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
Samuel D. Riccitelli Chief Executive Officer, President and Director
Signal Genetics, Inc.
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at